From Target to Therapy, Faster.

Access our proprietary database of 5,000+ oncology genes — each manually curated, prioritized by druggability tier, and mapped to existing approved drugs for repurposing.

• ✓Diamond, Gold, Silver, Bronze target classifications
• ✓Druggability annotations with evidence levels
• ✓Approved drug ↔ gene target repurposing maps
• ✓Targeting mechanism data (small molecule, antibody, etc.)
• ✓Searchable by disease area, gene, or drug

From raw sequencing data to actionable insights. Our team builds and runs custom NGS pipelines tailored to your research — RNA-seq, WES, WGS, and beyond.

• ✓End-to-end pipeline design and execution
• ✓Differential gene expression analysis
• ✓Variant calling and annotation
• ✓Pathway and gene ontology enrichment
• ✓Publication-ready figures and reports

Tell us your disease area and therapeutic hypothesis. We deliver a curated report with ranked targets, repurposing candidates, and the supporting evidence — ready for your discovery team.

• ✓Disease-specific target shortlists
• ✓Competitive landscape analysis per target
• ✓Literature evidence summaries
• ✓Repurposing candidates with rationale
• ✓Delivered within 2–4 weeks

Data Intake

FASTQ files, BAM/CRAM, or raw sequencer output from your NGS platform

QC & Alignment

Quality control, adapter trimming, and reference genome alignment

Analysis

Variant calling, differential expression, pathway enrichment

Target Mapping

Cross-reference with our 5,000-gene database for druggability and tier classification

Deliverables

Prioritized target list, repurposing candidates, publication-ready report

What sets us apart

Every gene in our database is manually curated against published literature and experimental data. No automated scraping, no unverified predictions.

Database Statistics